IL10 and neoplasm: In addition to focusing on increasing the number of NK cells and enhancing their killing ability, it is also necessary to explore strategies to overcome immunosuppressive tumor microenvironment, such as IL-6, IL-10 and TGFβ, that could mediate immune evasion of tumor cells for adoptive NK cells-based immunotherapy (58).